General Information
BounceWatch is an independent company data service, not affiliated with Austell Pharmaceuticals. To contact Austell Pharmaceuticals, visit austell.co.za.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Austell Pharmaceuticals compare?
A PDF of Austell Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Austell Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Austell Pharmaceuticals on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
South Africa Market
Biotechnology
About Austell Pharmaceuticals
Business keywords: pharmaceutical company, South Africa, growth, product portfolio, operations, development pipeline, medium-sized enterprise, ambitious, expertise, organizational efficiency, value-driven, strategic product selection, IMS Data, innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | Undisclosed | 1 |
Vantage Capital
|
12 Sep 2014 |
Austell Pharmaceuticals Alternatives & Competitors
View All AlternativesInnovation for Unmet Medical Needs
See further, go deeper, Deliver impact.
Sunesis is a biopharmaceutical company focused on the development and future commercialization of ne...
FAQ About Austell Pharmaceuticals
Source: BounceWatch company record for Austell Pharmaceuticals, https://bouncewatch.com/company/austell-pharmaceuticals, updated 31 December 2024. When citing, please name BounceWatch and link this page.